ACHE and Alzheimer disease: The filtered network maintained robust connectivity to established Alzheimer’s disease drug targets, including acetylcholinesterase, NMDA receptors, and amyloid-related proteins, with 89.7% of known AD drugs successfully retained in the filtered dataset.